Ptoms and signs. Prog Brain Res. 2006;152:1?. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol. 2001;24(5):254?4.Sengupta et al. Clin Proteom (2016) 13:Page 8 of47. Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp. 2011;71(2):281?9. 48. Tanhoffer RA, Yamazaki RK, Nunes EA, Pchevozniki AI, Pchevozniki AM, Nogata C, Aikawa J, Bonatto SJ, Brito G, Lissa MD, et al. Glutamine concentration and immune response of spinal cord-injured rats. J Spinal Cord Med. 2007;30(2):140?. 49. Massing MW, Robinson GA, Marx CE, Alzate O, Madison RD. Applications of proteomics to nerve regeneration research. In: Alzate O, editor. Neuroproteomics. Chapter 15. Boca Raton (FL): CRC Press/Taylor Francis; 2010. http://www.ncbi.nlm.nih.gov/books/NBK56006/. 50. Ambron RT, Walters ET. Priming events and retrograde injury signals. A new perspective on the cellular and molecular PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/15501003 biology of nerve regeneration. Mol Neurobiol. 1996;13(1):61?9. 51. Perlson E, Medzihradszky KF, Darula Z, Munno DW, Syed NI, Burlingame AL, Fainzilber M. Differential proteomics reveals multiple components in retrogradely transported axoplasm after nerve injury. Mol Cell Proteomics. 2004;3(5):510?0. 52. Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron. 2005;45(5):715?6. 53. Perlson E, Michaelevski I, Kowalsman N, Ben-Yaakov K, Shaked M, Seger R, Eisenstein M, Fainzilber M. Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase. J Mol Biol. 2006;364(5):938?4. 54. Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, et al. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma. 2010;27(4):669?2. 55. Chen A, McEwen ML, Sun S, Ravikumar R, Springer JE. Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats. J Neurotrauma. 2010;27(1):263?4. 56. Sengupta MB, Basu M, Iswarari S, Mukhopadhyay KK, Sardar KP, Acharyya B, Mohanty PK, Mukhopadhyay D. CSF proteomics of secondary phase spinal cord injury in human subjects: perturbed molecular pathways post injury. PLoS One. 2014; 9(10):e110885. doi:10.1371/journal. pone.0110885. 57. Lee JY, Kim BJ, Sim G, Kim GT, Kang D, Jung JH, Hwa JS, Kwak YJ, Choi YJ, Park YS, et al. Spinal cord injury markedly altered protein expression patterns in the affected rat urinary bladder during healing stages. J Korean Med Sci. 2011;26(6):814?3. 58. Yan X, Liu T, Yang S, Ding Q, Liu Y, Zhang X, Que H, Wei K, Luo Z, Liu S. Lenalidomide Proteomic profiling of the insoluble pellets of the transected rat spinal cord. J Neurotrauma. 2009;26(2):179?3. 59. Wang CY, Chen JK, Wu YT, Tsai MJ, Shyue SK, Yang CS, Tzeng SF. Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury. J Biomed Sci. 2011;18:13. 60. Tsai MC, Shen LF, Kuo HS, Cheng H, Chak KF. Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach. Mol Cell Proteomics. 2008;7(9):1668?7. 61. Lubieniecka JM, Streijger F, Lee JH, Stoynov N, Liu J, Mottus R, Pfeifer T, K.